- Home
- EPSN vs OPTN Comparison
EPSN vs OPTN Comparison
Compare EPSN & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPSN
- OPTN
- Stock Information
- Founded
- EPSN 2005
- OPTN 2010
- Country
- EPSN Canada
- OPTN United States
- Employees
- EPSN N/A
- OPTN N/A
- Industry
- EPSN Oil & Gas Production
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- EPSN Energy
- OPTN Health Care
- Exchange
- EPSN Nasdaq
- OPTN Nasdaq
- Market Cap
- EPSN 129.8M
- OPTN 78.4M
- IPO Year
- EPSN N/A
- OPTN 2017
- Fundamental
- Price
- EPSN $5.85
- OPTN $0.42
- Analyst Decision
- EPSN Strong Buy
- OPTN Strong Buy
- Analyst Count
- EPSN 1
- OPTN 3
- Target Price
- EPSN $7.00
- OPTN $3.00
- AVG Volume (30 Days)
- EPSN 25.3K
- OPTN 835.9K
- Earning Date
- EPSN 11-06-2024
- OPTN 11-12-2024
- Dividend Yield
- EPSN 4.33%
- OPTN N/A
- EPS Growth
- EPSN N/A
- OPTN N/A
- EPS
- EPSN 0.24
- OPTN N/A
- Revenue
- EPSN $31,145,315.00
- OPTN $75,672,000.00
- Revenue This Year
- EPSN N/A
- OPTN $13.42
- Revenue Next Year
- EPSN $15.65
- OPTN $52.99
- P/E Ratio
- EPSN $24.21
- OPTN N/A
- Revenue Growth
- EPSN N/A
- OPTN 5.13
- 52 Week Low
- EPSN $4.70
- OPTN $0.32
- 52 Week High
- EPSN $6.20
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- EPSN 50.47
- OPTN 35.42
- Support Level
- EPSN $5.67
- OPTN $0.39
- Resistance Level
- EPSN $6.00
- OPTN $0.57
- Average True Range (ATR)
- EPSN 0.22
- OPTN 0.05
- MACD
- EPSN -0.01
- OPTN -0.00
- Stochastic Oscillator
- EPSN 53.12
- OPTN 16.53
About EPSN Epsilon Energy Ltd. Common Share
Epsilon Energy Ltd is engaged in the acquisition, development, gathering, and production of natural gas and oil reserves. The operating segments of the company include Upstream segment activities including acquisition, development, and production of natural gas reserves on properties within the United States. The Gas Gathering segment partners with two other companies to operate a natural gas gathering system, and the corporate segment activities include corporate listing and governance functions of the corporation. The company generates revenue from the sale of crude oil and natural gas.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.